NYSE:ELVHealthcare
How Investors Are Reacting To Elevance Health (ELV) Slower EPS, Higher Dividend And 2026 Guidance
Elevance Health has released its fourth quarter and full-year 2025 results, reporting full-year revenue of US$199.13 billion, net income of US$5.66 billion, new 2026 earnings guidance, a first-quarter 2026 dividend of US$1.72 per share, and continued share repurchases.
Despite higher revenue, full-year earnings per share and profit margins eased, while the company still returned cash through dividends and buybacks.
We will now examine how Elevance Health’s slower earnings progression...